Skip to content

Ontwikkeling van een methode voor het bestuderen van de omzetting van beta-caroteen in vitamine A.

Method development to study the bioequivalence of ß-carotene: a pilot study in Dutch adults aged 18-35 years

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25920
Enrollment
16
Registered
2020-02-07
Start date
2020-03-02
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin A deficiency, bioequivalence

Interventions

Group A: 150 mcg retinol/day
Group B: 300 mcg retinol/day
Group C: 500 mcg retinol/day
Group D: 800 mcg retinol/day

Sponsors

Wageningen University & Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Female • Age: 18-35 years • Non-smoking • BMI 18-25 kg/m2 • Fluent in Dutch

Exclusion criteria

Exclusion criteria: ? Pregnant or lactating ? Metabolic diseases (diabetes, hypercholesterolemia) ? Disorder or use of drugs that interferes with fat-soluble vitamin absorption ? History of chronic diseases including renal disease, liver disease, diagnosed gastrointestinal disorders and cancer ? Allergic to food that will be provided during the study ? Recent major surgery, blood transfusion or blood donation (< 6 months ago) ? Dieting or having irregular dietary habits ? Use of (multi)vitamin preparations with vitamin A or ß-carotene up till 3 months before the start of the study ? Participation in another clinical trial ? Being an MSc student or employed at the Division of Human Nutrition and Health, Wageningen University

Design outcomes

Primary

MeasureTime frame
13C10 isotope enrichment in plasma retinol

Secondary

MeasureTime frame
Bioconversion of 13C10-betacarotene to 13C5-retinol

Contacts

Public ContactAlida Melse-Boonstra

Wageningen Universtiy & Research

alida.melse@wur.nl0317-484317

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)